Client News

Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies

Proxygen Appoints Chiara Conti, Ph.D., as Chief Scientific Officer to Drive Clinical Translation and Expand Induced Proximity Platform Beyond Degradation

AFYREN announces 2025 full-year financial results and the full takeover of its AFYREN NEOXY biorefinery

InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium

InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting

VeonGen Announces Clinical Progress of VG801 Gene Therapy in Stargardt Disease, with an Oral Presentation at ARVO 2026

Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion

MIG Capital Continues Successful Course in 2025 Despite a Challenging Market Environment

Newron presents 2025 financial results and provides 2026 outlook